• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Life Sciences
  • Investments
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage

WakeMed Taps Helix to Launch Precision Medicine Program

by Fred Pennic 10/02/2024 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

What You Should Know: 

– Helix, a leader in precision health, and WakeMed, a renowned not-for-profit health system in Raleigh, N.C., are joining forces to launch a large-scale precision medicine program in Wake County. 

– The precision medicine initiative aims to improve health outcomes for residents by providing access to personalized genetic insights, enhancing disease prevention efforts, and supporting local health research.

A Community-Wide Effort to Transform Healthcare

WakeMed and Helix aim to enroll 100,000 participants over four years, this program will be the largest of its kind in Wake County. Participation is voluntary and free of charge, allowing individuals to gain valuable information about their genetic predispositions to certain health conditions.

Empowering Individuals with Personalized Genetic Insights

Through the program, participants will receive information about their genetic risk for:

  • Certain cancers: Including hereditary breast and ovarian cancer, Lynch syndrome, and familial hypercholesterolemia.
  • A cause of heart disease: Familial hypercholesterolemia, a genetic condition that can lead to high cholesterol and an increased risk of heart attack and stroke.

Participants can also opt to receive information about their regional ancestry and genetic traits, such as caffeine sensitivity.

Leveraging Cutting-Edge Genomics Technology

Helix will utilize its end-to-end genomics platform and innovative “Sequence Once, Query Often®” model for this initiative. This approach allows for future genomic tests to be conducted without requiring additional patient samples, ensuring ongoing access to valuable health insights throughout participants’ lifetimes.

Improving Disease Prevention and Public Health

By screening a large population, WakeMed can identify genetic risks that may be prevalent in the local area and develop targeted health programs to address these specific needs. This proactive approach to disease prevention has the potential to significantly improve public health outcomes in Wake County and beyond.

“A community health research program developed through the strategic collaboration between WakeMed and Helix will help improve the health of the patients and the communities we serve,” said David Kirk, MD, chief clinical integration officer for WakeMed. “Having a better understanding of how DNA impacts our health brings us one step closer to learning about our genetic risk for common cancers and heart disease while increasing access to personalized medicine to all patients in our community.”

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Interview

Reach7 Diabetes Studios Founder Chun Yong on Reimagining Chronic Care with a Concierge Medical Model

Most-Read

HHS Finalizes HTI-4 Rule: Prior Authorization & E-Prescribing Interoperability

HHS Finalizes HTI-4 Rule: Prior Authorization & E-Prescribing Interoperability

Meaningful Use Penalties_Meaningful Use_Partial Code Free_Senators Urge CMS to Establish Clear Metrics for ICD-10 Testing

CMS Finalizes TEAM Model: A New Era of Value-Based Surgical Care

White House Event Unveils CMS Health Tech Ecosystem Initiative

White House Event Unveils CMS Health Tech Ecosystem Initiative

Digital Health Faces Q2'25 Pullback: Funding Falls to 5-Year Low, But AI Dominates and $1B+ IPOs Emerge

Healthcare Investment Shifts in 1H 2025: AI Remains a Bright Spot Amidst Fundraising Decline

Digital Health Faces Q2'25 Pullback: Funding Falls to 5-Year Low

Digital Health Faces Q2’25 Pullback: Funding Falls to 5-Year Low

Beyond the Hype: Building AI Systems in Healthcare Where Hallucinations Are Not an Option

Beyond the Hype: Building AI Systems in Healthcare Where Hallucinations Are Not an Option

Health IT Sector Navigates Policy Turbulence with Resilient M&A

Health IT’s New Chapter: IPOs Return, Resilient M&A, Valuations Rise in 1H 2025

PwC Report: US Medical Cost Trend to Remain Elevated at 8.5% in 2026

PwC Report: US Medical Cost Trend to Remain Elevated at 8.5% in 2026

Philips Launches ECG AI Marketplace, Partnering with Anumana to Enhance Cardiac Care with AI-Powered Diagnostics

Philips Launches ECG AI Marketplace, Partnering with Anumana to Enhance Cardiac Care with AI-Powered Diagnostics

WeightWatchers Emerges from Bankruptcy, Launches New Menopause Program

WeightWatchers Emerges from Bankruptcy, Launches New Menopause Program

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |